BRPI0816789A2 - Goji e inflamação - Google Patents

Goji e inflamação

Info

Publication number
BRPI0816789A2
BRPI0816789A2 BRPI0816789A BRPI0816789A2 BR PI0816789 A2 BRPI0816789 A2 BR PI0816789A2 BR PI0816789 A BRPI0816789 A BR PI0816789A BR PI0816789 A2 BRPI0816789 A2 BR PI0816789A2
Authority
BR
Brazil
Prior art keywords
goji
inflammation
Prior art date
Application number
Other languages
English (en)
Inventor
Olivier Ballevre
Peter Bucheli
Karine Vidal
Stéphanie Blum-Sperisen
David Philippe
Junkuan Wang
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of BRPI0816789A2 publication Critical patent/BRPI0816789A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A61K36/815—Lycium (desert-thorn)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
BRPI0816789 2007-09-12 2008-09-12 Goji e inflamação BRPI0816789A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07116190A EP2036568A1 (en) 2007-09-12 2007-09-12 Wolfberries and inflammation
PCT/EP2008/062122 WO2009034162A1 (en) 2007-09-12 2008-09-12 Wolfberries and inflammation

Publications (1)

Publication Number Publication Date
BRPI0816789A2 true BRPI0816789A2 (pt) 2015-03-17

Family

ID=38984201

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0816789 BRPI0816789A2 (pt) 2007-09-12 2008-09-12 Goji e inflamação

Country Status (16)

Country Link
US (2) US20100303741A1 (pt)
EP (3) EP2036568A1 (pt)
JP (1) JP2010540415A (pt)
CN (2) CN103417728A (pt)
AR (1) AR068448A1 (pt)
AU (1) AU2008297074A1 (pt)
BR (1) BRPI0816789A2 (pt)
CA (2) CA2699233C (pt)
CL (1) CL2008002692A1 (pt)
ES (1) ES2698199T3 (pt)
HK (1) HK1146229A1 (pt)
MX (1) MX2010002499A (pt)
PT (1) PT2200624T (pt)
RU (1) RU2499604C2 (pt)
TW (1) TW200930389A (pt)
WO (2) WO2009034162A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1096344A (en) * 1964-04-02 1967-12-29 Sandoz Ltd Improvements in or relating to organic compounds
TW201021821A (en) * 2008-12-10 2010-06-16 Fl Dauern Res Inc Formulations and methods for maintaining normal levels of catecholamines, glucocorticoids, androsteroids and their related hormones
KR101696504B1 (ko) * 2009-09-02 2017-01-13 액세스 비지니스 그룹 인터내셔날 엘엘씨 피부 복구용 조성물 및 방법
WO2011079212A2 (en) * 2009-12-24 2011-06-30 LifeSpan Extension, LLC Methods and compositions for identifying, producing and using plant-derived products modulating cell function and aging
CN103997899B (zh) 2011-06-20 2016-04-20 H.J.亨氏公司 益生菌组合物和方法
CN103027879A (zh) * 2011-09-29 2013-04-10 庞来祥 一种具有保湿作用的枸杞唇膏及其制备方法
IN2014MN02392A (pt) 2012-04-23 2015-08-21 Univ Oslo
GB201223365D0 (en) * 2012-12-24 2013-02-06 Provexis Natural Products Ltd Compositions
CN105997774A (zh) * 2016-05-10 2016-10-12 芜湖亮晶晶生物科技有限公司 一种止血消炎牙膏及其制备方法
EP3534725A1 (en) 2016-11-02 2019-09-11 Provexis Natural Products Limited Water soluble tomato extract protects against adverse effects of air pollution
CN106667937B (zh) * 2017-01-03 2020-01-17 河北省农林科学院经济作物研究所 一种黑枸杞多糖咀嚼片
TWI727584B (zh) 2019-06-20 2021-05-11 財團法人工業技術研究院 抑制皮膚細胞增生及/或抗發炎之組成物以及芹菜素與木犀草素在製備抑制皮膚細胞增生及/或抗發炎之組成物的用途
CN110742883A (zh) * 2019-12-05 2020-02-04 华南农业大学 二氢杨梅素在缓解呕吐毒素引起肠道细胞损伤中的应用
CN112022767B (zh) * 2020-09-17 2023-04-07 云南省药物研究所 一种抗炎抑菌增强免疫祛痘组合物及其应用
MX2024007249A (es) * 2021-12-20 2024-07-10 Soc Des Produits Nestle S A Proceso para preparar una composicion de bayas.
CN114209810B (zh) * 2022-01-06 2023-02-07 宁夏杞肽科技有限公司 枸杞糖肽在制备用于预防或治疗炎性肠病的药物中的用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1100949A (zh) * 1994-03-11 1995-04-05 李启才 金樱保健系列产品及其制法
CN1135338A (zh) * 1995-05-06 1996-11-13 孙秀英 芸杞保健茶
CN1296757A (zh) * 2000-07-09 2001-05-30 鄂来明 芦荟奶制品
WO2003057707A1 (en) * 2001-12-28 2003-07-17 Suntory Limited 2-o-( -d-glucopyranosyl)ascorbic acid, process for its production, and foods and cosmetics containing compositions comprising it
RU2302879C2 (ru) * 2002-04-09 2007-07-20 Сычуан Институте Оф Чайниз Материа Медика Фармацевтическая композиция для лечения ревматизма, способ ее приготовления и применение
TW200515914A (en) * 2002-11-08 2005-05-16 Wackvom Ltd Compositions containing an active fraction isolated from Lycium barbarum and methods of using the same
JPWO2005018656A1 (ja) * 2003-08-21 2006-10-19 株式会社カネカ 脳神経細胞死予防及び／または改善剤
CN1913888A (zh) * 2003-12-18 2007-02-14 荷兰联合利华有限公司 降低应激对皮肤调理的作用的方法
MY142017A (en) * 2004-03-19 2010-08-16 Nestec Sa Composition comprising all essential nutrients of a fruit or a plant material with increased stability and bioavailability and process of forming the same
US20060024339A1 (en) * 2004-07-29 2006-02-02 Howard Murad Methods of managing the redness associated with a dermatological condition
US7776915B2 (en) * 2005-03-24 2010-08-17 Tracie Martyn International, Llc Topical formulations and methods of use
JP2007176814A (ja) * 2005-12-27 2007-07-12 Yoshihiro Futamura 炎症性サイトカイン産生抑制作用を有するゼアキサンチン誘導体、それからなる食品製剤、化粧品、抗炎症剤

Also Published As

Publication number Publication date
EP2200624A1 (en) 2010-06-30
WO2009034165A1 (en) 2009-03-19
EP2200624B1 (en) 2018-09-05
EP2200623A1 (en) 2010-06-30
TW200930389A (en) 2009-07-16
WO2009034162A1 (en) 2009-03-19
RU2499604C2 (ru) 2013-11-27
RU2010114192A (ru) 2011-10-20
JP2010540415A (ja) 2010-12-24
CA2699233A1 (en) 2009-03-19
AU2008297074A1 (en) 2009-03-19
PT2200624T (pt) 2018-11-29
US20100221372A1 (en) 2010-09-02
CN101795699B (zh) 2013-07-10
US9072769B2 (en) 2015-07-07
CN103417728A (zh) 2013-12-04
CL2008002692A1 (es) 2009-10-16
EP2036568A1 (en) 2009-03-18
HK1146229A1 (en) 2011-05-20
CN101795699A (zh) 2010-08-04
AR068448A1 (es) 2009-11-18
ES2698199T3 (es) 2019-02-01
MX2010002499A (es) 2010-04-27
CA2698860A1 (en) 2009-03-19
CA2699233C (en) 2019-03-19
US20100303741A1 (en) 2010-12-02

Similar Documents

Publication Publication Date Title
BRPI0816789A2 (pt) Goji e inflamação
CY2015013I2 (el) Αντι-μολυσματικες πυραμιδινες και χρησεις αυτων
DK2170827T3 (da) Indolin-2-oner og aza-indolin-2-oner
BRPI0907231A2 (pt) pirrolpirimidinas e pirrolpiridinas
BRPI0809978A2 (pt) Dispositivos e métodos de dispensação de gotículas
BRPI0812367A2 (pt) Dispositivos interoclusais e respectivos métodos de fabrico
DK2185164T3 (da) Sammensætning og terapeutisk antitumorvaccine
DK2185552T3 (da) Dipeptoid-prodrugs og anvendelse heraf
DE602007010795D1 (de) Blattsauger und -häcksler
DK2220320T3 (da) Forseglet enhed og mellemstykke
DE112007000086A5 (de) Verbindungselement sowie Verbindungsanordnung
BRPI0810497A2 (pt) Refrigerador e dispositivo elétrico
BRPI0810142A2 (pt) Intercalação dinâmica de fluxos e entrega baseada em subfluxos
BRPI0813647A2 (pt) Piperazinil oxoalquil tetrahidro-beta-carbolinas e análogos relacionados
PL2036882T3 (pl) Związki o jonach obojnaczych i ich zastosowanie
FI20075881A (fi) Lääketieteellinen väline ja sen valmistus
DK2160336T3 (da) Forbindelsesmekanisme og fremgangsmåde
DK2086213T3 (da) Billedlæseapparat og billeddannelseapparat
BRPI0815203A2 (pt) gel contendo pirfenidona
FR2924738B1 (fr) Charniere
FI20075686A0 (fi) Konfigurointimenetelmä ja -laite
BRPI0821351A2 (pt) aparelhos e métodos
DK2252688T3 (da) Syntetiske phosphodiester-oligonukleotider og terapeutiske anvendelser deraf
DE602008002307D1 (de) Kupplungsanordnung und Verbindungsanordnung
BRPI0818598A2 (pt) agentes terapêuticos - 802

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 7A ANUIDADE.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.